ATRYS Stock Today

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>AH</div>
ATRYS HEALTH is trading at 5.34 as of the 27th of May 2020, which is 1.14% increase since the beginning of the trading day. The stock's open price was 5.28. ATRYS HEALTH has 53 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 30 trading days. Equity ratings for ATRYS HEALTH S are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 27th of February 2020 and ending today, the 27th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance3 100 


Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was founded in 2007 and is based in Barcelona, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 114 people. more on ATRYS HEALTH
Chief Executive OfficerIsabel FernandezView All
Thematic Classification
Currently Active Investing Idea
View All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ATRYS HEALTH available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short)
ATRYS HEALTH S (ATRY) is traded on Madrid SE C.A.T.S. in Spain and employs 114 people. The company currently falls under 'Small-Cap' category with current market capitalization of 112.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ATRYS HEALTH's market, we take the total number of it shares issued and multiply it by the ATRYS HEALTH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ATRYS HEALTH S operates under Healthcare sector and is part of Biotechnology industry. The entity has 21.45 M outstanding shares. The company has accumulated about 1.4 M in cash with 88.55 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check ATRYS HEALTH Probability Of Bankruptcy

ATRYS Stock Price Odds Analysis

Odds Down 5.34HorizonTargetOdds Up 5.34
86.91%30 days
Based on normal probability distribution, the odds of ATRYS HEALTH to move above current price in 30 days from now is about 13.01 (This ATRYS HEALTH S probability density function shows the probability of ATRYS HEALTH Stock to fall within a particular range of prices over 30 days) .

ATRYS HEALTH S Risk Profiles

ATRYS Stock Against Markets

Did you try this?

Run Portfolio Comparator Now


Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

ATRYS HEALTH Corporate Executives

Jose Ginesta Chief Financial Officer
Please continue to Trending Equities. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page